| 000 | 01065 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518083206.0 | ||
| 264 | 0 | _c20200615 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.119.028453 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchlemm, Ludwig | |
| 245 | 0 | 0 |
_aLetter by L. Schlemm and E. Schlemm Regarding Article, "Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity". _h[electronic resource] |
| 260 |
_bStroke _c03 2020 |
||
| 300 |
_ae54 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAspirin |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2C19 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aObesity |
| 650 | 0 | 4 | _aOverweight |
| 650 | 0 | 4 |
_aStroke _xgenetics |
| 700 | 1 | _aSchlemm, Eckhard | |
| 773 | 0 |
_tStroke _gvol. 51 _gno. 3 _gp. e54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.119.028453 _zAvailable from publisher's website |
| 999 |
_c30586410 _d30586410 |
||